Active — Not RecruitingNot Applicable

MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness

Norway120 participantsStarted 2011-10

Plain-language summary

The purpose of the study is to combine and correlate data from morphological and functional MRI, molecular signatures of tumor hypoxia, the presence of micrometastases and tumor hypoxia with the goal being predicting of prostate cancer aggressiveness.

Who can participate

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients suitable for surgery with confirmed prostate cancer, Gleason grade ≥ 3 * Patient has received no prior treatment for prostate cancer. * Patient has adequate renal function: Estimated creatinine clearance ≥ 60 ml/minute. * Patient must sign written informed consent according to the protocol approved by the Regional Ethics Committee. Exclusion Criteria: * Patient with contraindication to MR or MR contrast media according to clinical practice. * Patients who want to withdraw for any reason during the study. * Patients previously undergone pelvic surgery or radiation therapy

What they're measuring

Death

Timeframe: 2030

Trial details

NCT IDNCT01464216

SponsorOslo University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12

View on ClinicalTrials.gov More Prostatic Neoplasms trials